Cannabis Reduction and Functional Outcomes
ConditionCannabis Use Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University of South Carolina
About this trial
This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing, computerized cognitive behavioral therapy (CBT4CBT), and financial incentives for reduction in urinary cannabinoids. The study aims to assess improvements in cannabis-related problems, sleep, cognitive performance, CUD severity, and quality of life.
Eligibility criteria
Qualifiers
Age 18+
Urinary cannabinoid level ≥ 50 ng/mL
DSM-5 diagnosis of CUD (mild, moderate, or severe)
Willingness to attempt cannabis reduction
Disqualifiers
Serious medical/psychiatric conditions
Pregnancy or breastfeeding
Use of cannabis in past 30 days was for medical purposes only
Discontinuation or reduction of cannabis use may exacerbate a pre-existing condition
Trial design
Treatments tested in this trial
- CBT4CBT (Computerized Cognitive Behavioral Therapy)
- Motivational Interviewing
- Contingency Management
Treatment groups
No treatment groups listed
Sponsors and collaborators
Medical University of South Carolina
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov